PharmaEssentia Corporation
PharmaEssentia Corporation is a Taiwan-based company in the Healthcare sector with a market capitalisation of $15.0B. Its FinScore is 71/100; its highest-scoring layer is Growth (96) and its lowest is Value (31). The shares trade at 67.4x trailing earnings and are up 164% year to date.
Share price performance
About PharmaEssentia Corporation
www.pharmaessentia.comPharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing therapies for human ailments, serving both the Taiwanese and international markets. Its product portfolio prominently features Ropeginterferon alfa-2b, indicated for the management of various hematological conditions including chronic myelogenous leukemia, T-Cell leukemia, early myelofibrosis, polycythemia vera, and essential thrombocythemia. Beyond this, the company's pipeline includes TCRT, anti PD-1, PEG-cytokine X,Y, and novel checkpoint antibodies, all under development for solid tumors. A specific combination, P1101 + anti PD-1, is being explored for hepatocellular carcinoma, while PEG-GCSF addresses neutropenia. Fundamentally, its comprehensive research and development initiatives span key therapeutic areas such as hematology, infectious diseases, and oncology. Established in 1990, PharmaEssentia Corporation maintains its headquarters in Taipei, Taiwan.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- HQ
- Taiwan
- Fiscal year-end
- December
- Trading currency
- TWD
- Reporting currency
- TWD
- Fundamentals updated
- 68 days ago
- Market cap
- $15.0B
- Shares outstanding
- 413.6M
- P/E (TTM)
- 67.4x
- Dividend yield (TTM)
- 0.13%
- Beta (issuer)
- 0.65
- Revenue (latest FY)
- NT$15.6B
Revenue breakdown
Revenue split not available
FinScore
As of 2026-10-19Snapshot
Ownership
Holder data is not available for this company yet.
Sign up or log in to see Analysis
Analysis for PharmaEssentia Corporation is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Financials
Financials for PharmaEssentia Corporation is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Estimates
Estimates for PharmaEssentia Corporation is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Peers
Peers for PharmaEssentia Corporation is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Valuation
Valuation for PharmaEssentia Corporation is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see News
News for PharmaEssentia Corporation is available to Finryse members. The Overview stays open to everyone; creating an account is free.